Visit COVID-19 resources

[Skip to Content]

Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren’s syndrome – (Eye 29, 1204 (September 2015))

10 September 2015

This news item is available to RCOphth members only, please log in below to access.

Members Login